Physician
General Surgery
Dr. Juan P. Arnoletti, MD
|
|
Give Review
Doctor Juan P. Arnoletti, MD is an expert in the field of General Surgery. He has 2 awards "Regional Top Doctor" and "Fellow (FACS)". Doctor Juan P. Arnoletti, MD is a published MD. He has 51 papers published. The most current publication "Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-..." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic Ductal adenocarcinoma in patient-derived xenograft models.
- Outcomes after implementing a tailored endoscopic step-up approach to walled-off necrosis in acute pancreatitis.
- Beyond cytology: why and when does the oncologist require core tissue?
- Recent Developments in Surgery: Minimally Invasive Approaches for Patients Requiring Pancreaticoduodenectomy.
- Endoscopic ultrasound evaluation in the surgical treatment of duodenal and peri-ampullary adenomas.
- Primary Pancreatic Ewing's Sarcoma with Portal Vein Tumor Thrombosis.
- Mucinous Cystic Neoplasm of the Pancreas.
- Tamoxifen enhances therapeutic effects of gemcitabine on cholangioCarcinoma tumorigenesis.
- Serum biomarker panels for the detection of pancreatic Cancer.
- ErbB3 expression promotes tumorigenesis in pancreatic adenoCarcinoma.
- Molecular mechanisms of tamoxifen therapy for cholangioCarcinoma: role of calmodulin.
- Laparoscopic assistance for endoscopic resection of early stage esophageal Cancer (with video).
- A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic Cancer.
- Response markers and the molecular mechanisms of action of Gleevec in gastroIntestinal stromal tumors.
- Preoperative chemoradiation in the management of adenoCarcinoma of the body of the pancreas.
- Development and histopathological characterization of tumorgraft models of pancreatic Ductal adenocarcinoma.
- Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic Cancer.
- Surgical treatment of Pancreatic endocrine neoplasms.
- Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.
- Cyclooxygenase-2 expression and clinical outcome in gastroIntestinal stromal tumors.
- Hairy cell leukemia: a diagnosis by endoscopic ultrasound guided fine needle aspiration.
- Neoadjuvant and adjuvant therapy for Rectal cancer.
- Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during coloRectal tumorigenesis.
- Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in coloRectal cancer.
- Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.
- Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenoCarcinoma cells.
- Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with resectable Rectal cancer.
- Pancreatic adenoCarcinoma. Clinical Practice Guidelines in Oncology.
- Rectal cancer.
- EGFR genomic gain and aberrant pathway signaling in pancreatic Cancer patients.
- Fine needle aspiration of an axillary lymph node in a patient suspected of having metastatic Cancer of unknown primary.
- ErbB3 expression and dimerization with EGFR influence pancreatic Cancer cell sensitivity to erlotinib.
- Pancreatic Cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.
- Heparin-induced thrombocytopenia in coronary bypass surgery.
- Surgical treatment of benign hepatic mass lesions.
- Early postoperative complications of splenectomy for hematologic Disease.
- ReDuction of transfusion requirements during major hepatic resection for metastatic disease.
- Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-...
- Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) proDuction ...
- Computer-assisted image Analysis of tumor sections for a new thrombospondin receptor.
- A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advance...
- Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenoCarcinoma.
- NCCN clinical practice guidelines in oncology. Anal carcinoma.
- Occult primary Cancer clinical practice guidelines.
- NCCN Clinical Practice Guidelines in Oncology: Rectal cancer.
- NCCN Clinical Practice Guidelines in Oncology: colon Cancer.
- Epigenetic downregulation of the DNA repair gene MED1/MBD4 in coloRectal and ovarian cancer.
- Radiofrequency ablation for unresectable tumors of the Liver.
- Colon Cancer.
- Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic Ductal adenocarcinoma.
Schools
Universidad De La Republica Facultad De Medicina
McPHahnemann
Fox Chase Cancer Center
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Care HMO
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Fellow (FACS)
Education
-
Drexel University - Hahnemann University Hospital -
Universidad de La Republica Faculty of Medicine
Hospital
-
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1528071289 | |
| NPPES Provider LastName | ARNOLETTI | |
| NPPES Provider FirstName | JUAN | |
| NPPES Provider ZIPCode | 32804 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 121.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 9.92 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528071289 |
| Last Name Of The Provider | ARNOLETTI |
| First Name Of The Provider | JUAN |
| View All |
Similar Doctors
|
Dr. Florencio J. Gonzalez, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Muhammad Z. Jawad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael B. Freeland, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jean F. Miner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Delos R. Clift, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Owen D. Fraser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luke M. Elms, MD |
|
|
Dr. Hugo V. Hart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Loudon, MD |
|
|
Dr. Enrique E. Vega, MD |
|
|
Dr. Alyssa J. Wier, MD |